HIV-1 latency reversal and immune enhancing activity of IL-15 is not influenced by sex hormones

The role of different biological variables including biological sex, age, and sex hormones in Human immunodeficiency virus (HIV) cure approaches is not well understood. The gamma c-cytokine IL-15 is a clinically relevant cytokine that promotes immune activation and mediates HIV reactivation from latency. In this work, we examined the interplay that biological sex, age, and sex hormones 17(3-estradiol, progesterone, and testosterone may have on the biological activity of IL-15. We found that IL-15-mediated CD4+T + T cell activation was higher in female donors than in male donors. This difference was abrogated at high 17(3-estradiol concentration. Additionally, there was a positive correlation between age and both IL-15-mediated CD8+ + T cell activation and IFN-gamma production. In a primary cell model of latency, biological sex, age, or sex hormones did not influence the ability of IL-15 to reactivate latent HIV. Finally, 17(3-estradiol did not consistently affect reactivation of translation-competent reservoirs in CD4+ + T cells from people living with HIV who are antiretroviral therapy (ART) suppressed. Our study has found that biological sex and age, but not sex hormones, may influence some of the biological activities of IL-15. Understanding how different biological variables may affect HIV cure therapies will help us evaluate current and future clinical trials aimed toward HIV cure in diverse populations.